MFST trades most of the time at generally undervalued levels considering the company's assets and future growth potential. Any time new investors discover this issue they are likely to want to establish at least a starter position. Any positive news that is released on here is likely to result in gains for those who are holding the stock.
From the company profile:
Medifirst Solutions, Inc., in response to its Premarket Notification 510(k) submission for The Time Machine Series Laser, received clearance from the U.S. Food and Drug Administration to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The Time Machine Series Lasers Model TTML-8102000 - 810/830nm is intended for use in temporary relief of minor muscle and joint pain, stiffness, minor arthritis pain, muscle spasm, temporary increase in local blood circulation and temporary relaxation of muscles by means of topical elevated tissue temperature from infrared spectral emissions. Due to the decrease of inflammation, patients have seen immediate aesthetic improvements as well, such as in scar healing and incisions. The hand-held laser device, with pin-point accuracy, often gives patients immediate results with no redness, swelling or down-time. This unique laser device offers medical professionals an affordable and effective tool to enhance their treatment protocols for their patients and provide new revenue streams for their practice. The laser division will be operated out of Medifirst's wholly owned subsidiary, Medical Lasers Manufacturer.
News 
Market Data 
Discover 
